BioCorRx Inc.
BICX· OTC
Filed Mar 31, 2026 · 10-K · 90 days after period end · 0001477932-26-001807
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $18.94K | $82.88K |
| Net Income | $552.55K | -$1.23M | -$969.01K | -$1.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end